ARCHIVES

NCI Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 33 No. 5 | May 28, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough

August 20, 1976

ACCC Considers Role Of Allied Personnel, Funds, Center Components

February 13, 1976

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999